Prognostic Analysis for Cardiogenic Shock in Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention

Table 5

Cox proportional hazard ratio of recurrent myocardial infarction, cardiovascular mortality, all-cause mortality, and repeated-PCI in AMI patients with cardiogenic shock after index PCI.

Variable	Recurrent MI		CV mortality		All-cause mortality		Repeat-PCI
	Adjusted HR	value	Adjusted HR	value	Adjusted HR	value	Adjusted HR	value
With CS	1.57	0.442	4.51	<0.00	3.66	<0.00	2.93	<0.00
Age	1.03	0.094	1.06	<0.00	1.06	<0.00	1.02	0.01
Male	1.42	0.424	0.74	0.332	1.03	0.904	1.08	0.798
SYNTAX score	1.03	0.163	1.03	0.00	1.03	0.00	0.98	0.078
Comorbidity
STEMI	2.53	0.870	2.85	0.308	3.16	0.251	5.02	0.740
Non-STEMI	5.78	0.758	3.28	0.258	4.72	0.128	6.20	0.707
DM	1.89	0.087	1.76	0.04	1.46	0.088	1.54	0.043
Dyslipidemia	0.91	0.817	0.91	0.737	0.98	0.931	0.87	0.540
Smoke	0.63	0.273	1.13	0.724	0.80	0.403	1.67	0.02
Stroke	3.19	0.03	2.04	0.075	2.53	0.00	1.09	0.873
Medications
Aspirin	0.86	0.814	1.42	0.463	0.60	0.068	1.98	0.191
P2Y12 inhibitors	0.84	0.778	2.03	0.336	0.90	0.790	1.51	0.384
Diuretics	1.33	0.466	1.09	0.793	1.02	0.937	1.27	0.355
BB	0.83	0.610	0.42	0.00	0.50	0.00	1.02	0.938
ACEI	1.06	0.889	0.48	0.03	0.64	0.078	0.41	<0.00
Statin	0.67	0.379	0.57	0.129	0.50	0.02	0.93	0.784

Recurrent MI: recurrent myocardial infarction; CV mortality: cardiovascular mortality; CS: cardiogenic shock; SYNTAX score: Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery score; DM: diabetes mellitus; STEMI: ST-segment elevation myocardial infarction; Non-STEMI: non- ST-segment elevation myocardial infarction; P2Y12 inhibitors: P2Y12 receptor inhibitor of platelet; BB: beta-blockers; ACEI: angiotensin-converting enzyme inhibitors Significant.